[(2S,3S,5S)-6-[[(2R,3S,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (4aS,6aS,6bR,10S,12aR)-10-[(2R,3S,5R)-4-[(2S,3S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(3S,4R,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate

Details

Top
Internal ID ecc7489a-db4c-45ab-bde7-edb0ade9e536
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Triterpene glycosides > Triterpene saponins
IUPAC Name [(2S,3S,5S)-6-[[(2R,3S,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (4aS,6aS,6bR,10S,12aR)-10-[(2R,3S,5R)-4-[(2S,3S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(3S,4R,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
SMILES (Canonical) CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(CC4C6=CCC7C8(CCC(C(C8CCC7(C6(CC5)C)C)(C)C)OC9C(C(C(C(O9)CO)O)OC1C(C(C(C(O1)CO)O)OC1C(C(C(CO1)O)O)O)O)O)C)(C)C)O)O)O)CO)O)O)O
SMILES (Isomeric) CC1[C@@H](C([C@@H]([C@@H](O1)O[C@@H]2C(O[C@H]([C@H](C2O)O)OCC3[C@H](C([C@@H]([C@@H](O3)OC(=O)[C@@]45CC[C@@]6(C(=CCC7[C@]6(CCC8[C@@]7(CC[C@@H](C8(C)C)O[C@H]9[C@H](C([C@@H](C(O9)CO)O)O[C@H]1[C@H](C([C@@H](C(O1)CO)O)OC1[C@H]([C@@H]([C@@H](CO1)O)O)O)O)O)C)C)C4CC(CC5)(C)C)C)O)O)O)CO)O)O)O
InChI InChI=1S/C65H106O31/c1-25-36(70)41(75)45(79)55(87-25)93-50-31(22-68)90-53(47(81)43(50)77)86-24-32-38(72)42(76)46(80)56(91-32)96-59(84)65-17-15-60(2,3)19-27(65)26-9-10-34-62(6)13-12-35(61(4,5)33(62)11-14-64(34,8)63(26,7)16-18-65)92-57-48(82)52(40(74)29(20-66)88-57)95-58-49(83)51(39(73)30(21-67)89-58)94-54-44(78)37(71)28(69)23-85-54/h9,25,27-58,66-83H,10-24H2,1-8H3/t25?,27?,28-,29?,30?,31?,32?,33?,34?,35+,36+,37-,38-,39-,40-,41?,42?,43?,44+,45+,46+,47+,48+,49+,50-,51?,52?,53-,54?,55+,56+,57+,58+,62+,63-,64-,65+/m1/s1
InChI Key FWZFJTSLNSCMKS-UFBIDWOVSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C65H106O31
Molecular Weight 1383.50 g/mol
Exact Mass 1382.6718066 g/mol
Topological Polar Surface Area (TPSA) 492.00 Ų
XlogP -2.80
Atomic LogP (AlogP) -4.72
H-Bond Acceptor 31
H-Bond Donor 18
Rotatable Bonds 16

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(2S,3S,5S)-6-[[(2R,3S,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (4aS,6aS,6bR,10S,12aR)-10-[(2R,3S,5R)-4-[(2S,3S,5R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(3S,4R,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.7891 78.91%
Caco-2 - 0.8723 87.23%
Blood Brain Barrier - 0.6250 62.50%
Human oral bioavailability - 0.7714 77.14%
Subcellular localzation Mitochondria 0.8567 85.67%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8030 80.30%
OATP1B3 inhibitior - 0.5700 57.00%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 0.6276 62.76%
BSEP inhibitior + 0.9098 90.98%
P-glycoprotein inhibitior + 0.7440 74.40%
P-glycoprotein substrate - 0.5723 57.23%
CYP3A4 substrate + 0.7375 73.75%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8587 85.87%
CYP3A4 inhibition - 0.9300 93.00%
CYP2C9 inhibition - 0.8838 88.38%
CYP2C19 inhibition - 0.9101 91.01%
CYP2D6 inhibition - 0.9422 94.22%
CYP1A2 inhibition - 0.8933 89.33%
CYP2C8 inhibition + 0.7496 74.96%
CYP inhibitory promiscuity - 0.9668 96.68%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.6254 62.54%
Eye corrosion - 0.9900 99.00%
Eye irritation - 0.8982 89.82%
Skin irritation - 0.6103 61.03%
Skin corrosion - 0.9480 94.80%
Ames mutagenesis - 0.7500 75.00%
Human Ether-a-go-go-Related Gene inhibition + 0.7724 77.24%
Micronuclear - 0.8600 86.00%
Hepatotoxicity - 0.9250 92.50%
skin sensitisation - 0.8917 89.17%
Respiratory toxicity - 0.5444 54.44%
Reproductive toxicity + 0.9000 90.00%
Mitochondrial toxicity - 0.7625 76.25%
Nephrotoxicity - 0.9618 96.18%
Acute Oral Toxicity (c) III 0.7945 79.45%
Estrogen receptor binding + 0.7710 77.10%
Androgen receptor binding + 0.7411 74.11%
Thyroid receptor binding + 0.6264 62.64%
Glucocorticoid receptor binding + 0.7794 77.94%
Aromatase binding + 0.6599 65.99%
PPAR gamma + 0.8201 82.01%
Honey bee toxicity - 0.6408 64.08%
Biodegradation - 0.7500 75.00%
Crustacea aquatic toxicity - 0.5305 53.05%
Fish aquatic toxicity + 0.9411 94.11%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.19% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.05% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 94.80% 97.09%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 92.99% 95.17%
CHEMBL3714130 P46095 G-protein coupled receptor 6 92.79% 97.36%
CHEMBL1293249 Q13887 Kruppel-like factor 5 92.16% 86.33%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 90.83% 94.45%
CHEMBL226 P30542 Adenosine A1 receptor 89.33% 95.93%
CHEMBL2581 P07339 Cathepsin D 89.15% 98.95%
CHEMBL1806 P11388 DNA topoisomerase II alpha 88.90% 89.00%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 87.09% 96.77%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 86.98% 95.50%
CHEMBL1994 P08235 Mineralocorticoid receptor 85.87% 100.00%
CHEMBL218 P21554 Cannabinoid CB1 receptor 84.92% 96.61%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 84.81% 95.56%
CHEMBL5255 O00206 Toll-like receptor 4 84.03% 92.50%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 83.80% 86.92%
CHEMBL253 P34972 Cannabinoid CB2 receptor 80.66% 97.25%
CHEMBL5028 O14672 ADAM10 80.31% 97.50%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Meryta lanceolata

Cross-Links

Top
PubChem 162972756
LOTUS LTS0175699
wikiData Q105003736